STMicroelectronics (ENXTPA:STMPA) Stock Faces Thin 3.6% Margin Despite Q2 Earnings Swing

STMicroelectronics (ENXTPA:STMPA) has reported Q2 2026 revenue of US$3.5 billion and basic EPS of US$0.25, with net income of US$222 million giving investors a clear snapshot of its latest quarter. The company has seen quarterly revenue move from US$2,766 million in Q2 2025 to US$3,487 million in Q2 2026, while basic EPS has shifted from a loss of US$0.11 to a profit of US$0.25 over the same period. This sets the stage for a closer look at how top line and EPS trends are feeding through to margins and the broader growth story.

See our full analysis for STMicroelectronics.

With the headline numbers on the table, the next step is to weigh these results against the most common narratives around STMicroelectronics, highlighting where the recent earnings support those views and where the margin profile raises fresh questions.

See what the community is saying about STMicroelectronics

ENXTPA:STMPA Revenue & Expenses Breakdown as at Jul 2026
ENXTPA:STMPA Revenue & Expenses Breakdown as at Jul 2026
Advertisement

Net margin still thin at 3.6%

  • On a trailing 12 month view, STMicroelectronics generated US$13.1 billion of revenue and US$466 million of net income, which works out to a 3.6% net profit margin compared with 5.5% last year.
  • Consensus narrative highlights long term margin improvement, but the current 3.6% trailing margin and a large one off loss of US$295 million show that profitability is still sensitive to shocks.
    • The margin gap versus last year plus the one off loss sit alongside forecasts for 11.9% yearly revenue growth and 37.7% yearly earnings growth, so the near term numbers are weaker than the growth story suggests.
    • Investors weighing that consensus view can use the Q2 2026 net income of US$222 million and basic EPS of US$0.25 as a reference point for how much improvement would be needed for margins to reach those forecast levels.

High 101.9x P/E sets a high bar

  • The stock trades on a 101.9x P/E, which is above both the European semiconductor industry average of 55.1x and the peer average of 10.8x, despite trailing 12 month earnings of US$466 million on US$13.1 billion of revenue.
  • Consensus narrative points to revenue growth of 11.9% per year and earnings growth of 37.7% per year, so the current 101.9x P/E and share price of €46.77 leave little room if that growth or margin recovery is slower than expected.
    • The analyst price target used here is €65.25, which sits above the current price, while the DCF fair value of €24.52 is considerably lower, so different approaches are giving very different signals on what the stock might be worth.
    • That spread between the 101.9x P/E and a DCF fair value below the current price encourages investors to check whether the forecast jump from a 3.6% trailing margin to higher future margins fits with their own expectations.

Earnings swing supports the bullish case

  • Quarterly net income moved from a loss of US$97 million in Q2 2025 to a profit of US$222 million in Q2 2026, while basic EPS shifted from a loss of US$0.11 to US$0.25 over the same period.
  • Bulls argue that growing automotive and Edge AI demand, together with capacity investments, could drive much stronger earnings, and the step up from US$37 million net income in Q1 2026 to US$222 million in Q2 2026 gives them some recent support to point to.
    • The bullish narrative in the data assumes revenue could grow 19.5% annually with margins rising from 1.2% to 23.3%, which is a big jump compared with the current 3.6% trailing margin and US$466 million of trailing earnings.
    • Those bullish assumptions also imply earnings in the billions of dollars by 2029, so readers can use the latest quarterly run rate and trailing 12 month totals to judge how ambitious that path looks.
On these numbers, the bullish camp is effectively asking whether STMicroelectronics can turn a recent US$222 million quarterly profit into multi billion dollar yearly earnings within a few years, which is a big stretch from the current base but not impossible if the business delivers on its pipeline and margin plans. 🐂 STMicroelectronics Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for STMicroelectronics on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given the mix of bullish expectations and valuation questions around STMicroelectronics, it makes sense to move quickly and test the narrative against the full risk and reward picture using the 1 key reward and 3 important warning signs.

See What Else Is Out There Beyond STMicroelectronics

STMicroelectronics carries a thin 3.6% trailing net margin and a high 101.9x P/E, with profitability still sensitive to one off hits and ambitious earnings expectations.

If that mix of tight margins and a rich valuation makes you cautious, it is worth checking out companies in the 293 resilient stocks with low risk scores that pair more resilient financial profiles with steadier return characteristics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About ENXTPA:STMPA

STMicroelectronics

Designs, develops, manufactures, and sells semiconductor products in Europe, the Middle East, Africa, the Americas, and the Asia Pacific.

Flawless balance sheet with reasonable growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
37 users have followed this narrative
2 users have commented on this narrative
6 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
59 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
21 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
19 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

AE
ASML logo
Aequitas on ASML Holding ·

ASML Will Reign as the Kingpin of the Semiconductor Supply Chain

Fair Value:€1.87k16.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AE
FTNT logo
Aequitas on Fortinet ·

Fortinet, compounding Cyber Security Player.

Fair Value:US$116.8430.4% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AE
CSU logo
Aequitas on Constellation Software ·

Constellation Software: A Proven Serial Acquirer at a Discount

Fair Value:CA$3.72k28.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
70 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
70 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
TR
tripledub
GOOGL logo
tripledub on Alphabet ·

Warren Buffett Just Bet $10 Billion on Google. The Catch? You May Already Be Too Late.

Fair Value:US$23039.0% overvalued
92 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

0
|
0